FGB rs1800787: What Your Genotype Means
The rs1800787 variant is a single nucleotide polymorphism located in the promoter region of the FGB gene. It is primarily studied for its potential influence on basal fibrinogen production and its association with the risk of ischemic stroke.
What each genotype means
Typical fibrinogen promoter profile
This genotype represents the common version of the FGB promoter region. Research into this variant, also known as -148C/T, has produced conflicting results regarding its influence on stroke or cardiovascular risk, and it is not considered a diagnostic marker. You should discuss any concerns about cardiovascular health or blood clotting factors with your healthcare provider.
This is the most common genotype across most global populations.
Common variant promoter profile
You carry one copy of the T allele at this position in the FGB gene. While some studies have explored whether this variant influences fibrinogen levels or vascular health, the evidence remains inconsistent and limited. This result does not provide a clear clinical prediction, and you should consult your physician for personalized cardiovascular risk assessment.
This heterozygous genotype is found in a significant portion of the population, with the minor allele frequency typically ranging between 0.15 and 0.25.
Elevated risk association profile
Some early research has suggested that individuals with this homozygous genotype may have an increased statistical association with carotid atherosclerosis compared to those with other genotypes. However, other studies have found no significant link to cardiovascular disease, and the overall evidence is considered limited and contradictory. Please discuss your cardiovascular health and any relevant family history with your doctor.
This genotype is less common than the C/C and C/T configurations, occurring in a smaller subset of the population.
Understanding the rs1800787 Variant
The rs1800787 variant is a common genetic change located on chromosome 4 within the FGB gene. In scientific literature, this specific polymorphism is frequently referred to as the -148C/T variant, indicating its position within the promoter region of the gene. A promoter is a segment of DNA that acts as a control switch, determining how much of a specific protein is produced by the cell. Because this variant sits in a regulatory area, researchers have long hypothesized that it may alter the expression levels of the fibrinogen protein. While it is a well-documented site in genetic databases, the functional impact of this change can vary, and its role in human health is considered a subject of ongoing investigation rather than a definitive diagnostic marker.
The Role of the FGB Gene
The FGB gene provides the essential instructions for creating the fibrinogen beta chain, which is one of three subunits that combine to form the functional fibrinogen protein. Fibrinogen is a critical glycoprotein circulating in the blood that plays a central role in hemostasis, the process that stops bleeding after an injury. When a blood vessel is damaged, fibrinogen is converted into fibrin, a sticky, thread-like protein that forms the structural mesh of a blood clot. Because fibrinogen levels must be tightly regulated to ensure proper clotting without causing excessive thickness in the blood, variations in the genes that control its production—such as FGB—are of significant interest to cardiovascular researchers. Proper fibrinogen function is vital for maintaining the balance between preventing hemorrhage and avoiding the formation of dangerous, unwanted clots.
Research Associations and Evidence Strength
Research into rs1800787 has primarily focused on its association with ischemic stroke and cardiovascular health. Some studies have suggested that the presence of the T allele may correlate with higher basal fibrinogen levels, which in turn could theoretically influence stroke risk. However, the evidence supporting this link is considered limited and often inconsistent across different populations. For instance, while some case-control studies have reported higher risks for carriers of certain genotypes, other meta-analyses have failed to find a significant association between this specific SNP and conditions like coronary artery disease. The complexity of stroke, which involves many genetic and environmental factors, makes it difficult to isolate the effect of a single variant. Consequently, current scientific consensus views this variant as a potential modulator rather than a primary cause of disease.
Population Frequency
The rs1800787 variant is relatively common, with a minor allele frequency typically reported between 0.15 and 0.25 across diverse global populations. This means that a significant portion of the general population carries at least one copy of the variant allele, making it a standard feature of human genetic diversity rather than a rare mutation.
Interpreting Your Genetic Information
It is important to understand that having a specific genotype for rs1800787 does not constitute a medical diagnosis or a definitive prediction of future health outcomes. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to the health of an individual. Many factors, including lifestyle, diet, environment, and other genetic markers, contribute to cardiovascular health and stroke risk. If you are concerned about your fibrinogen levels or your risk for stroke, you should consult with a qualified healthcare provider. They can evaluate your personal and family medical history to provide appropriate guidance. Never use genetic information to make changes to your medications or health regimen without first discussing these decisions with your clinician or pharmacist.
How common is this variant?
The minor allele frequency for rs1800787 is approximately 0.15 to 0.25 across diverse populations, indicating that the variant is widely distributed.
Frequently asked questions
Is rs1800787 a cause of stroke?
No, rs1800787 is not considered a direct cause of stroke. It is a genetic variant that has been statistically associated with stroke risk in some studies, but these associations are complex and often inconsistent.
Does this variant mean I have high fibrinogen?
Not necessarily. While some research suggests a potential link between this variant and fibrinogen levels, many other factors influence protein production in the body. A blood test is the only way to accurately measure your actual fibrinogen levels.
Should I change my medication based on this result?
No. You should never change your medication or treatment plan based on genetic test results without consulting your doctor or pharmacist. Genetic data is only one piece of a much larger health picture.
Where can I find more information on FGB?
You can find reliable information about the FGB gene and its function on resources like MedlinePlus Genetics or the GeneCards database. These sites provide comprehensive overviews of gene function and related health topics.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800787?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29